ResearcherSemmelweis UniversityActive in the last 2 years
Ákos Szűcs
Matched on ORCID iD 0000-0002-7366-2174; OpenAlex author ID A5103800013. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 18
2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Prognostic value of microRNA expression in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Last author DOI 10.1016/j.ebiom.2026.106528↗
- Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis. Last author DOI 10.3389/pore.2022.1610266↗
- Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technolog… Co-author DOI 10.1007/s00018-020-03703-8↗
- Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience. Co-author DOI 10.1007/s12253-016-0176-0↗
- Pancreatic Cancer: Multicenter Prospective Data Collection and Analysis by the Hungarian Pancreatic Study Group. Co-author DOI 10.15403/jgld.2014.1121.252.pcr↗
- [Pancreatic cancer. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Co-author DOI 10.1556/oh.2015.30063↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Péter Jenő Hegyi · 4 shared papers, 2015–2022 · strength 0.31
- Paper Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A M… DOI 10.3389/pore.2022.1610266↗
- Paper Efficacy and Safety of FOLFIRINOX in Locally Advanced Pancreatic Cancer. A Single Center Experience. DOI 10.1007/s12253-016-0176-0↗
- Paper Pancreatic Cancer: Multicenter Prospective Data Collection and Analysis by the Hungarian Pancreatic Study Group. DOI 10.15403/jgld.2014.1121.252.pcr↗
- Ștefania Bunduc · 1 shared paper, 2026 · strength 0.29
- Lőrinc Ulmann · 1 shared paper, 2026 · strength 0.29
- Márton Benke · 1 shared paper, 2022 · strength 0.15
- Anikó Zeöld · 1 shared paper, 2021 · strength 0.12
- Zoltán Wiener · 1 shared paper, 2021 · strength 0.12
- Attila Bursics · 1 shared paper, 2021 · strength 0.12
- Gábor Lakatos · 2 shared papers, 2016–2017 · strength 0.12
- Richárd Szmola · 2 shared papers, 2015–2016 · strength 0.08
- Dezső Kelemen · 2 shared papers, 2015–2016 · strength 0.08
- László Czakó · 2 shared papers, 2015–2016 · strength 0.08
- Gyorgy Bodoky · 1 shared paper, 2017 · strength 0.08
- Anita Balázs · 1 shared paper, 2016 · strength 0.04
- Zsuzsanna Kahán · 1 shared paper, 2016 · strength 0.04
- Zoltán Szepes · 1 shared paper, 2016 · strength 0.04
- Ákos Pap · 1 shared paper, 2015 · strength 0.04
- Attila Oláh · 1 shared paper, 2015 · strength 0.04
- Miklós Sahin‐Tóth · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.